Research Article
MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study
Figure 1
The expression levels of the MYL5 gene in pan-tumors and normal tissues. The expression levels of MYL5 in different types of tumor tissues and normal tissues were analyzed by using the Oncomine database (the threshold of value is 0.01, fold change is 2, and gene ranking is all) (a), TIMER 2.0 (b) and GEPIA2 (c) tools (d). The expression levels of the MYL5 gene were analyzed by the main pathological stages of BRCA and TGCT. Log2 (TPM + 1) was applied for the log-scale. , , and .
(a) |
(b) |
(c) |
(d) |